China SXT Pharmaceuticals, Inc. (SXTC) › Operating Cash FlowChina SXT Pharmaceuticals, Inc. (SXTC) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2017: $293.0K2018: $1.92M2019: $239.2K2020: $934.2K2021: -$1.32M2022: $268.3K2023: -$80.8K2024: -$1.93M2025: -$2.35M-$2.35M2017Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$2.35M-21.6%2024-$1.93M-2287.5%2023-$80.8K-130.1%2022$268.3K+120.4%2021-$1.32M-240.9%2020$934.2K+290.6%2019$239.2K-87.5%2018$1.92M+555.3%2017$293.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share